This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Non-Hodgkin lymphoma
  • /
  • Efficacy and safety of tositumomab and iodine-131 ...
Journal

Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.

Read time: 1 mins
Published:25th Mar 2020
Author: Horning SJ, Younes A, Jain V, Kroll S, Lucas J, Podoloff D, et al.
Availability: Free full text
Ref.:J Clin Oncol. 2005;23:712-19.
DOI:10.1200/JCO.2005.07.040
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest